Blister packs to limit the supply of opioids per patient will be the first item the FDA will pursue once the opioids legislation becomes law, the agency’s chief said Oct. 18.
President Donald Trump could sign the massive opioids bill the week of Oct. 22. The bill (H.R. 6) is in response to a public health epidemic that takes 115 lives a day in the U.S.
The legislation includes a new authority for the Food and Drug Administration to require opioid manufacturers such as Purdue Pharma and Johnson & Johnson to develop new packaging for the powerful painkillers, ...